Primary Site >> Colorectal Cancer

Gene >> RAF1

Journal: Princess Takamatsu Symp. 1986;17:75-84.
Title: Activation of rat and human c-raf(-1) by rearrangement.
Author: Nagao, M|Ishikawa, F|Tahira, T|Ochiai, M|Sugimura, T
PMID: 3332022
Journal: Nucleic Acids Res. 1987 Jun 25;15(12):4809-20.
Title: Activation of human c-raf-1 by replacing the N-terminal region with different sequences.
Author: Tahira, T|Ochiai, M|Hayashi, K|Nagao, M|Sugimura, T
PMID: 2955285
Journal: Cancer. 1993 Feb 1;71(3):672-6.
Title: Multiple polyps of esophagus, stomach, colon, and rectum accompanying rectal cancer in a patient with constitutional chromosomal inversion.
Author: Sasajima, K|Yamanaka, Y|Inokuchi, K|Takizawa, T|Ujihara, Y|Ide, Y|Onda, M|Takubo, K
PMID: 8431846
Journal: Dig Dis Sci. 1996 Jun;41(6):1069-75.
Title: Raf-1 kinase, epidermal growth factor receptors, and mutant Ras proteins in colonic carcinomas.
Author: Eggstein, S|Manthey, G|Hirsch, T|Baas, F|Specht, B U|Farthmann, E H
PMID: 8654136
Journal: Cancer Res. 1996 Jun 15;56(12):2872-6.
Title: Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.
Author: Li, Y|White, R
PMID: 8665528
Journal: Cytometry. 1997 Sep 1;29(1):1-27.
Title: Common patterns of genetic evolution in human solid tumors.
Author: Shackney, S E|Shankey, T V
PMID: 9298807
Journal: Oncogene. 1998 Apr 9;16(14):1899-902.
Title: Abrogation of c-Raf expression induces apoptosis in tumor cells.
Author: Lau, Q C|Brusselbach, S|Muller, R
PMID: 9583688
Journal: Br J Cancer. 2002 Sep 23;87(7):783-9.
Title: Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin.
Author: Liu, D|Hutchinson, O C|Osman, S|Price, P|Workman, P|Aboagye, E O
PMID: 12232764
Journal: Biochim Biophys Acta. 2003 Jun 5;1653(1):25-40.
Title: Raf proteins and cancer: B-Raf is identified as a mutational target.
Author: Mercer, Kathryn E|Pritchard, Catrin A
PMID: 12781369
Journal: J Cell Sci. 2003 Dec 15;116(Pt 24):4957-63.
Title: Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Author: Vial, Emmanuel|Marshall, Christopher J
PMID: 14625389
Journal: Carcinogenesis. 2004 Apr;25(4):527-33. Epub 2003 Dec 19.
Title: Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.
Author: Fransen, Karin|Klintenas, Maria|Osterstrom, Anna|Dimberg, Jan|Monstein, Hans-Jurg|Soderkvist, Peter
PMID: 14688025
Journal: Postepy Hig Med Dosw (Online). 2004;58:428-37.
Title: [Complex forms of immune insufficiency to some cytokines (TNF-alpha, interferons) in colorectal cancers as exemplified by the COLO 205 cell line. Mechanism of resistance with special reference to signaling proteins and cytokines].
Author: Pajak, Beata|Orzechowski, Arkadiusz
PMID: 15577750
Journal: Oncogene. 2004 Mar 11;23(10):1885-95.
Title: Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway.
Author: Wang, Xiaofu|Wang, Qingding|Hu, Wanqin|Evers, B Mark
PMID: 14981539
Journal: J Nutr. 2004 Feb;134(2):483-6.
Title: Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells.
Author: Im, Eunok|Martinez, Jesse D
PMID: 14747693
Journal: Cancer Biol Ther. 2005 Oct;4(10):1159-67. Epub 2005 Oct 23.
Title: Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.
Author: Caraglia, Michele|Marra, Monica|Budillon, Alfredo|Meo, Giuseppina|Ricciardiello, Filippo|Bismuto, Ettore|Brachelente, Giovanni|Francini, Guido|Giordano, Antonio|Correale, Pierpaolo|Abbruzzese, Alberto
PMID: 16294035
Journal: J Cell Sci. 2006 Mar 1;119(Pt 5):819-27. Epub 2006 Feb 14.
Title: APC inhibits ERK pathway activation and cellular proliferation induced by RAS.
Author: Park, Ki-Sook|Jeon, Soung Hoo|Kim, Sung-Eun|Bahk, Young-Yil|Holmen, Sheri L|Williams, Bart O|Chung, Kwang-Chul|Surh, Young-Joon|Choi, Kang-Yell
PMID: 16478791
Journal: J Mol Med (Berl). 2007 Mar;85(3):293-304. Epub 2006 Dec 2.
Title: Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
Author: Lassmann, Silke|Weis, Roland|Makowiec, Frank|Roth, Jasmine|Danciu, Mihai|Hopt, Ulrich|Werner, Martin
PMID: 17143621
Journal: Mol Cancer Ther. 2007 Apr;6(4):1198-211.
Title: Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues.
Author: Sharp, Swee Y|Prodromou, Chrisostomos|Boxall, Kathy|Powers, Marissa V|Holmes, Joanna L|Box, Gary|Matthews, Thomas P|Cheung, Kwai-Ming J|Kalusa, Andrew|James, Karen|Hayes, Angela|Hardcastle, Anthea|Dymock, Brian|Brough, Paul A|Barril, Xavier|Cansfield, Jul
PMID: 17431102
Journal: Genes Chromosomes Cancer. 2008 Mar;47(3):253-9.
Title: SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.
Author: Swanson, Kenneth D|Winter, Jordan M|Reis, Marcelo|Bentires-Alj, Mohamed|Greulich, Heidi|Grewal, Rupinder|Hruban, Ralph H|Yeo, Charles J|Yassin, Yosuf|Iartchouk, Oleg|Montgomery, Kate|Whitman, Susan P|Caligiuri, Michael A|Loh, Mignon L|Gilliland, D Gary|Lo
PMID: 18064648
Journal: Mol Cancer Ther. 2008 Apr;7(4):915-22.
Title: Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells.
Author: Serova, Maria|Ghoul, Aida|Benhadji, Karim A|Faivre, Sandrine|Le Tourneau, Christophe|Cvitkovic, Esteban|Lokiec, Francois|Lord, Janet|Ogbourne, Steven M|Calvo, Fabien|Raymond, Eric
PMID: 18413805
Journal: Oncogene. 2009 Jan 15;28(2):157-69.
Title: Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.
Author: Smith, J R|Clarke, P A|de Billy, E|Workman, P
PMID: 18931700
Journal: PLoS One. 2009 May 27;4(5):e5717.
Title: Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.
Author: Jaiswal, Bijay S|Janakiraman, Vasantharajan|Kljavin, Noelyn M|Eastham-Anderson, Jeffrey|Cupp, James E|Liang, Yuxin|Davis, David P|Hoeflich, Klaus P|Seshagiri, Somasekar
PMID: 19492075
Journal: Sheng Li Ke Xue Jin Zhan. 2009 Jul;40(3):214-8.
Title: [Phosphatidylethanolamine-binding protein (PEBP) in basic and clinical study].
Author: Li, Fang-Fang|Song, Shi-Jun|Zhang, Ruo-Nan
PMID: 19803424
Journal: PLoS Comput Biol. 2009 Dec;5(12):e1000601.
Title: Human cancer protein-protein interaction network: a structural perspective.
Author: Kar, Gozde|Gursoy, Attila|Keskin, Ozlem
PMID: 20011507
Journal: Gastroenterology. 2010 Jun;138(7):2357-67.
Title: Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells.
Author: Hoogwater, Frederik J H|Nijkamp, Maarten W|Smakman, Niels|Steller, Ernst J A|Emmink, Benjamin L|Westendorp, B Florien|Raats, Danielle A E|Sprick, Martin R|Schaefer, Uta|Van Houdt, Winan J|De Bruijn, Menno T|Schackmann, Ron C J|Derksen, Patrick W B|Medema,
PMID: 20188103
Journal: PLoS One. 2012;7(8):e40392.
Title: Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients.
Author: Brim, Hassan|Lee, Edward|Abu-Asab, Mones S|Chaouchi, Mohamed|Razjouyan, Hadi|Namin, Hassanzadeh|Goel, Ajay|Schaffer, Alejandro A|Ashktorab, Hassan
PMID: 22879877
Journal: Carcinogenesis. 2012 Dec;33(12):2398-408.
Title: MAP kinase genes and colon and rectal cancer.
Author: Slattery, Martha L|Lundgreen, Abbie|Wolff, Roger K
PMID: 23027623
Journal: PLoS One. 2012;7(9):e44642.
Title: Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.
Author: Sharp, Swee Y|Roe, S Mark|Kazlauskas, Egidijus|Cikotiene, Inga|Workman, Paul|Matulis, Daumantas|Prodromou, Chrisostomos
PMID: 22984537
Journal: Cancer Genet. 2012 Oct;205(10):501-7.
Title: Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population.
Author: Azimzadeh, Pedram|Romani, Sara|Mohebbi, Seyed Reza|Mahmoudi, Touraj|Vahedi, Mohsen|Fatemi, Seyed Reza|Zali, Narges|Zali, Mohammad Reza
PMID: 22939228
Journal: Int J Oncol. 2012 Nov;41(5):1855-62.
Title: Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells.
Author: Subramanian, Romesh R|Yamakawa, Akio
PMID: 22922669
Journal: Expert Opin Investig Drugs. 2012 Jun;21(6):879-89.
Title: Regorafenib for cancer.
Author: Strumberg, Dirk|Schultheis, Beate
PMID: 22577890
Journal: Cancer Discov. 2012 Mar;2(3):227-35.
Title: EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.
Author: Corcoran, Ryan B|Ebi, Hiromichi|Turke, Alexa B|Coffee, Erin M|Nishino, Michiya|Cogdill, Alexandria P|Brown, Ronald D|Della Pelle, Patricia|Dias-Santagata, Dora|Hung, Kenneth E|Flaherty, Keith T|Piris, Adriano|Wargo, Jennifer A|Settleman, Jeffrey|Mino-Kenu
PMID: 22448344
Journal: J Cell Mol Med. 2013 Oct;17(10):1316-24.
Title: Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway.
Author: Luo, Wenjuan|Wang, Xiaoli|Zheng, Lei|Zhan, Yingzhuan|Zhang, Dongdong|Zhang, Jie|Zhang, Yanmin
PMID: 23905676
Journal: Int J Cancer. 2013 Nov;133(9):2089-101.
Title: Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
Author: Martinelli, Erika|Troiani, Teresa|D'Aiuto, Elena|Morgillo, Floriana|Vitagliano, Donata|Capasso, Anna|Costantino, Sarah|Ciuffreda, Loreta Pia|Merolla, Francesco|Vecchione, Loredana|De Vriendt, Veerle|Tejpar, Sabine|Nappi, Anna|Sforza, Vincenzo|Martini, Giu
PMID: 23629727
Journal: Nutr Cancer. 2013;65(5):729-38.
Title: Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer.
Author: Slattery, Martha L|Lundgreen, Abbie|Wolff, Roger K
PMID: 23859041
Journal: PLoS One. 2013 Jul 3;8(7):e67583.
Title: Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions.
Author: King, Alastair J|Arnone, Marc R|Bleam, Maureen R|Moss, Katherine G|Yang, Jingsong|Fedorowicz, Kelly E|Smitheman, Kimberly N|Erhardt, Joseph A|Hughes-Earle, Angela|Kane-Carson, Laurie S|Sinnamon, Robert H|Qi, Hongwei|Rheault, Tara R|Uehling, David E|Laquer
PMID: 23844038
Journal: PLoS Genet. 2013 Apr;9(4):e1003464.
Title: Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
Author: Giacomini, Craig P|Sun, Steven|Varma, Sushama|Shain, A Hunter|Giacomini, Marilyn M|Balagtas, Jay|Sweeney, Robert T|Lai, Everett|Del Vecchio, Catherine A|Forster, Andrew D|Clarke, Nicole|Montgomery, Kelli D|Zhu, Shirley|Wong, Albert J|van de Rijn, Matt|Wes
PMID: 23637631
Journal: Expert Opin Med Diagn. 2013 Mar;7(2):137-46.
Title: Novel biomarkers for the prediction of metastasis in colorectal cancer.
Author: Zlobec, Inti
PMID: 23530884
Journal: Expert Opin Investig Drugs. 2013 Jun;22(6):739-49.
Title: Phase I/II RAF kinase inhibitors in cancer therapy.
Author: Turajlic, Samra|Ali, Zohra|Yousaf, Nadia|Larkin, James
PMID: 23642225
Journal: Gastroenterology. 2014 May;146(5):1301-12.e1-10.
Title: PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Author: Li, Xin|Stevens, Payton D|Liu, Jianyu|Yang, Haihua|Wang, Wei|Wang, Chi|Zeng, Zheng|Schmidt, Micheal D|Yang, Mike|Lee, Eun Y|Gao, Tianyan
PMID: 24530606
Journal: Expert Opin Drug Discov. 2014 Sep;9(9):1087-101.
Title: The preclinical development of regorafenib for the treatment of colorectal cancer.
Author: Miura, Koh|Satoh, Masayuki|Kinouchi, Makoto|Yamamoto, Kuniharu|Hasegawa, Yasuhiro|Philchenkov, Alex|Kakugawa, Yoichiro|Fujiya, Tsuneaki
PMID: 24896071
Journal: Cancer Discov. 2014 Oct;4(10):1182-1197.
Title: Development of siRNA payloads to target KRAS-mutant cancer.
Author: Yuan, Tina L|Fellmann, Christof|Lee, Chih-Shia|Ritchie, Cayde D|Thapar, Vishal|Lee, Liam C|Hsu, Dennis J|Grace, Danielle|Carver, Joseph O|Zuber, Johannes|Luo, Ji|McCormick, Frank|Lowe, Scott W
PMID: 25100204
Journal: PLoS One. 2014 Dec 26;9(12):e116169.
Title: The influence of the CHIEF pathway on colorectal cancer-specific mortality.
Author: Slattery, Martha L|Lundgreen, Abbie
PMID: 25541970
Journal: Oncogene. 2015 Jan 2;34(1):15-26.
Title: Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.
Author: Smith, J R|de Billy, E|Hobbs, S|Powers, M|Prodromou, C|Pearl, L|Clarke, P A|Workman, P
PMID: 24292678
Journal: Tumour Biol. 2015 Feb;36(2):1313-21.
Title: MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
Author: Chai, Jie|Wang, Shan|Han, Dali|Dong, Wei|Xie, Chao|Guo, Hongliang
PMID: 25355599
Journal: Am J Pathol. 2015 Apr;185(4):1135-44.
Title: Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells.
Author: Peng, Hui|Li, Tony W H|Yang, Heping|Moyer, Mary P|Mato, Jose M|Lu, Shelly C
PMID: 25794709
Journal: Mar Drugs. 2015 Jun 5;13(6):3625-39.
Title: Activation of RAF1 (c-RAF) by the Marine Alkaloid Lasonolide A Induces Rapid Premature Chromosome Condensation.
Author: Josse, Rozenn|Zhang, Yong-Wei|Giroux, Valentin|Ghosh, Arun K|Luo, Ji|Pommier, Yves
PMID: 26058013
Journal: Mol Cancer Ther. 2015 Dec;14(12):2700-11.
Title: Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors.
Author: Whittaker, Steven R|Cowley, Glenn S|Wagner, Steve|Luo, Flora|Root, David E|Garraway, Levi A
PMID: 26351322
Journal: J Enzyme Inhib Med Chem. 2016;31(sup2):111-122.
Title: Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
Author: Gamal El-Din, Mahmoud M|El-Gamal, Mohammed I|Abdel-Maksoud, Mohammed S|Yoo, Kyung Ho|Baek, Daejin|Choi, Jungseung|Lee, Huiseong|Oh, Chang-Hyun
PMID: 27255180
Journal: PLoS One. 2016 Jul 6;11(7):e0156971.
Title: Human Blood Autoantibodies in the Detection of Colorectal Cancer.
Author: Negm, Ola H|Hamed, Mohamed R|Schoen, Robert E|Whelan, Richard L|Steele, Robert J|Scholefield, John|Dilnot, Elizabeth M|Shantha Kumara, H M C|Robertson, John F R|Sewell, Herbert F
PMID: 27383396
Journal: Proteomics. 2016 May;16(10):1557-69.
Title: Mechanistic study of the anti-cancer effect of Gynostemma pentaphyllum saponins in the Apc(Min/+) mouse model.
Author: Tai, William Chi-Shing|Wong, Wing-Yan|Lee, Magnolia Muk-Lan|Chan, Brandon Dow|Lu, Cheng|Hsiao, Wen-Luan Wendy
PMID: 26970558
Journal: Cell Cycle. 2016;15(4):506-18.
Title: Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation.
Author: Lochhead, Pamela A|Clark, Jonathan|Wang, Lan-Zhen|Gilmour, Lesley|Squires, Matthew|Gilley, Rebecca|Foxton, Caroline|Newell, David R|Wedge, Stephen R|Cook, Simon J
PMID: 26959608
Journal: FEBS Lett. 2016 Jun;590(11):1641-50.
Title: IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195.
Author: Ye, Song|Song, Wei|Xu, Xiaogang|Zhao, Xinyi|Yang, Liu
PMID: 27153315
Journal: Br J Cancer. 2017 Jun 27;117(1):136-143.
Title: Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
Author: Chakrabarty, Sanjiban|Varghese, Vinay Koshy|Sahu, Pranoy|Jayaram, Pradyumna|Shivakumar, Bhadravathi M|Pai, Cannanore Ganesh|Satyamoorthy, Kapaettu
PMID: 28524162
Journal: Life Sci. 2017 Aug 15;183:37-44.
Title: Discovery of a novel pan-RAF inhibitor with potent anti-tumor activity in preclinical models of BRAF(V600E) mutant cancer.
Author: Hong, Sung Pyo|Ahn, Soon Kil
PMID: 28645859
Journal: Biochem Biophys Res Commun. 2017 Jul 15;489(1):14-20.
Title: AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes.
Author: Wang, Hongbin|Quan, Haitian|Lou, Liguang
PMID: 28536078
Journal: Org Biomol Chem. 2017 Apr 18;15(16):3455-3465.
Title: Rational design, synthesis, and biological evaluation of Pan-Raf inhibitors to overcome resistance.
Author: Wang, Lu|Zhu, Gaoyuan|Zhang, Qing|Duan, Chunqi|Zhang, Yanmin|Zhang, Zhimin|Zhou, Yujun|Lu, Tao|Tang, Weifang
PMID: 28368067
Journal: Clin Cancer Res. 2017 Jul 15;23(14):3918-3928.
Title: Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.
Author: Weng, Wenhao|Wei, Qing|Toden, Shusuke|Yoshida, Kazuhiro|Nagasaka, Takeshi|Fujiwara, Toshiyoshi|Cai, Sanjun|Qin, Huanlong|Ma, Yanlei|Goel, Ajay
PMID: 28174233
Journal: Oncotarget. 2017 Feb 7;8(6):9251-9266.
Title: LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.
Author: Vakana, Eliza|Pratt, Susan|Blosser, Wayne|Dowless, Michele|Simpson, Nicholas|Yuan, Xiu-Juan|Jaken, Susan|Manro, Jason|Stephens, Jennifer|Zhang, Youyan|Huber, Lysiane|Peng, Sheng-Bin|Stancato, Louis F
PMID: 27999210
Journal: Gut. 2017 Jun;66(6):1106-1115.
Title: Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer.
Author: Borovski, Tijana|Vellinga, Thomas T|Laoukili, Jamila|Santo, Evan E|Fatrai, Szabolcs|van Schelven, Susanne|Verheem, Andre|Marvin, Dieuwke L|Ubink, Inge|Borel Rinkes, Inne H M|Kranenburg, Onno
PMID: 27670374
Journal: Oncogene. 2017 Jan 19;36(3):423-428.
Title: Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.
Author: Doudican, N A|Orlow, S J
PMID: 27321184
Journal: Food Chem Toxicol. 2018 Feb;112:11-18.
Title: Enhancement of colon carcinogenesis by the combination of indole-3 carbinol and synbiotics in hemin-fed rats.
Author: de Moura, Nelci A|Caetano, Brunno F R|de Moraes, Leonardo N|Carvalho, Robson F|Rodrigues, Maria A M|Barbisan, Luis F
PMID: 29269057
Journal: Medicine (Baltimore). 2018 Feb;97(7):e9738.
Title: Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Author: Yang, Chun-Wei|Wang, Shu-Fang|Yang, Xiang-Li|Wang, Lin|Niu, Lin|Liu, Ji-Xiang
PMID: 29443735
Journal: Oncotarget. 2017 Dec 27;9(5):6086-6094.
Title: Construction of key signal regulatory network in metastatic colorectal cancer.
Author: Qi, Lu|Ding, Yanqing
PMID: 29464057
Journal: Evid Based Complement Alternat Med. 2018 Feb 12;2018:6517034.
Title: A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer.
Author: Liu, Xinkui|Wu, Jiarui|Zhang, Dan|Wang, Kaihuan|Duan, Xiaojiao|Zhang, Xiaomeng
PMID: 29619072
Journal: FASEB J. 2018 Aug 14:fj201800336R.
Title: Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response.
Author: Nixon, Benjamin R|Sebag, Sara C|Glennon, Michael S|Hall, Eric J|Kounlavong, Emily S|Freeman, Michael L|Becker, Jason R
PMID: 30106602
Journal: Cell Cycle. 2018 Nov 1.
Title: Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.
Author: Ye, Cheng-Yu|Zheng, Cui-Ping|Ying, Wei-Wei|Weng, Shan-Shan
PMID: 30382763